International Chemical Investors Group

HOME ⤏ WHO WE ARE ⤏ CORDENPHARMA

Full-Service CDMO Partner

  • Formed in 2006 as the pharmaceutical brand of ICIG
  • Full-Service CDMO organized in 4 distinctive platforms with specialized characteristics
  • Marketing & Sales provided by CordenPharma International for separately managed operating companies (legal and financial independence)
  • 8 GMP production facilities in Europe and the United States
  • € 390 million total sales
  • 1,530 employees

Key Technologies
Drug Substance

Small Molecule Intermediates & APIs
Excipients
Peptides
Lipids
Carbohydrates
Conjugates
Highly Potent API’s
Oncology API’s
Sterile API’s

Key Technologies
Drug Product

Injectables (Vials, Ampoules, Pre-filled Syringes)
Sterile Emulsion Technology
Oral Solid Dosage Forms
Coated & Uncoated Tablets
Hard Gelatine Capsules
Sterile Liquid & Lyophilisation (Vials & Ampules)
Primary & Secondary Packaging
Blister & Bottle Packaging
Serialisation & 2D Data Matrix Coding
Clinical Trial Services

visit the website

www.cordenpharma.com
ICIG PLATFORMS
 

OUR SITES

› Homepage
› Our Approach
› Our Investments
› News
› Sitemap
› Contact

ABOUT

› Who we are
› WeylChem
› Vynova

› Enterprises

INTERNATIONAL CHEMICAL INVESTORS S.E.

LUXEMBOURG

2A, Rue des Capucins
L-1313 Luxembourg
Phone + 352 226972
Fax +352 27620782

 

GERMANY

An der Hauptwache 5
D-60313 Frankfurt
Phone +49 (69) 506 999-0
Fax +49 (69) 506 999-11

E-Mail: info @ ic-investors.com • www.ic-investors.com

LEGAL NOTICE | PRIVACY POLICY
www.ic-investors.com | www.icig-bs.com

OUR SITES

› Homepage
› Our Approach
› Our Investments
› News
› Sitemap
› Contact

ABOUT

› Who we are
› WeylChem
› Vynova
› Enterprises

INTERNATIONAL CHEMICAL INVESTORS S.E.

LUXEMBOURG

2A, Rue des Capucins
L-1313 Luxembourg
Phone + 352 226972
Fax +352 27620782

GERMANY

An der Hauptwache 5
D-60313 Frankfurt
Phone +49 (69) 506 999-0
Fax +49 (69) 506 999-11

E-Mail: info @ ic-investors.com
www.ic-investors.com